Biohaven (BHVN) Return on Equity (2022 - 2026)

Biohaven has disclosed Return on Equity across 5 years of filings, most recently posting 0.07% for Q1 2026.

• Return on Equity for Q1 2026 came in at 0.07%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 0.07% (changed N/A YoY), and the FY2025 annual result was 0.28%, down 24.0% from the prior year.
• Return on Equity came in at 0.07% for Q1 2026 at Biohaven, up from 0.42% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 100.22% in Q2 2024 to a low of 0.42% in Q4 2025.
• The 5-year median for Return on Equity is 0.02% (2023), against an average of 15.43%.
• Across the five-year window, Return on Equity surged 8986 bps in 2023 and plunged 2684 bps in 2024, its largest moves.
• Biohaven's Return on Equity stood at 0.02% in 2022, then retreated by 7 bps to 0.02% in 2023, then soared by 177 bps to 0.01% in 2024, then plunged by 2997 bps to 0.42% in 2025, then soared by 83 bps to 0.07% in 2026.
• The last three Return on Equity figures came in at 0.07% (Q1 2026), 0.42% (Q4 2025), and 0.11% (Q3 2025), per Business Quant data.